An advertisement from Eli Lilly hangs on a building in Gurugram, India. (Archive photo). Photo: Bhawika Chhabra/Reuters
Novo rival signs billion-dollar deal with AI firm
Eli Lilly has entered a $2.75 billion agreement with Insilico Medicine, a biotech firm utilizing generative artificial intelligence for drug discovery. Insilico, which has developed at least 28 drugs via AI, grants Eli Lilly exclusive licenses to develop, produce, and market certain oral drugs....
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?